Possible cellular mechanism accounting for the cell type-specific vulnerability in Huntington's disease
Centonze, D.; Giacomini, P.; Tolu, M.; Bernardi, G.; Calabresi, P.
Functional Neurology 15(4): 253-258
2000
ISSN/ISBN: 0393-5264 PMID: 11213528 Document Number: 514957
Document emailed within 1 workday
Related Documents
Maksimović, I.D.; Jovanović, M.D.; Colić, M.; Mihajlović, R.; Mićić, D.; Selaković, V.; Ninković, M.; Malicević, Z.; Rusić-Stojiljković, M.; Jovicić, A. 2001: Oxidative damage and metabolic dysfunction in experimental Huntington's disease: selective vulnerability of the striatum and hippocampus Vojnosanitetski Pregled 58(3): 237-242Shoji, M. 2004: Alzheimer type dementia and Huntington's disease Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 4): 154-158
Nukina, N. 1999: The function of Huntington disease gene product (huntingtin) and the pathomechanism of Huntington disease Nihon Rinsho. Japanese Journal of Clinical Medicine 57(4): 905-911
Sanberg, P.R.; Koutouzis, T.K.; Freeman, T.B.; Emerich, D.F.; Bertino, A.M.; Cahill, D.W. 1992: Cell transplantation for Huntington's disease Transplantation Proceedings 24(6): 3015-3016
Kaposy, C. 2010: Accounting for vulnerability to illness and social disadvantage in pandemic critical care triage Journal of Clinical Ethics 21(1): 23-29
Wedege, E. 1979: Properties of a brain-specific protein fraction which absorbs anti-neuronal antibodies in sera from patients with Huntington's disease Cellular and Molecular Biology Including Cyto-Enzymology 25(3): 207-213
Nielson, E.G.; Phillips, S.M. 1981: Cell-mediated immunity in interstitial nephritis. IV. Anti-tubular basement membrane antibodies can function in antibody-dependent cellular cytotoxicity reactions: observations on a nephritogenic effector mechanism acting as an informational bridge between the humoral and cellular immune response Journal of Immunology 126(5): 1990-1993
Kitsak, V.I.; Berdina, E.E.; Posevaia, T.A.; Chaplygina, N.M.; Orlova, N.G. 1983: Mechanism of the cellular transformation of newborn hamsters inoculated with herpes simplex type 2 virus Voprosy Virusologii 28(4): 79-84
Takekawa, F.; Nagumo, T.; Shintani, S.; Hashimoto, K.; Kikuchi, H.; Katayama, T.; Ishihara, M.; Amano, O.; Kawase, M.; Sakagami, H. 2007: Tumor-specific cytotoxic activity and type of cell death induced by 4-trifluoromethylimidazoles in human oral squamous cell carcinoma cell lines Anticancer Research 27(6b): 4065-4069
Bradley, T.P.; Bonavida, B. 1982: Mechanism of cell-mediated cytotoxicity at the single cell level. V. the importance of target cell structure in cytotoxic T lymphocyte-mediated antigen nonspecific lectin-dependent cellular cytotoxicity Journal of Immunology 129(6): 2352-2356
Bradley, T.P.; Bonavida, B. 1982: Mechanism of cell-mediated cytotoxicity at the single cell level. IV. Natural killing and antibody-dependent cellular cytotoxicity can be mediated by the same human effector cell as determined by the two-target conjugate assay Journal of Immunology 129(5): 2260-2265
Barski, G.; Youn, J.K.; Belehradek, J.; Le François, D. 1972: Variations of cellular type specific immunological defense mechanisms as a function of tumor growth Annales de l'Institut Pasteur 122(4): 633-643
Lee, N.P.Y.; Cheng, C.Y. 2004: Ectoplasmic specialization, a testis-specific cell-cell actin-based adherens junction type: is this a potential target for male contraceptive development? Human Reproduction Update 10(4): 349-369
Matsuoka, M. 2010: Mechanism of oncogenesis by human T-cell leukemia virus type 1 Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(1): 10-13
Vistica, D.T.; Schuette, B.P. 1981: Carrier mechanism and specificity accounting for the increase in intracellular melphalan by the basic amino acids Molecular Pharmacology 19(1): 92-96
Kato, H.; Takeuchi, O.; Akira, S. 2006: Cell type specific involvement of RIG-i in antiviral responses Nihon Rinsho. Japanese Journal of Clinical Medicine 64(7): 1244-1247
Siecker, B.R. 1979: Uniform cost accounting system for pharmacy: taking command of your accounting needs American Pharmacy 19(2): 14-20
Grimaldi, P.L.; Bertko, J.M. 1989: FASB (Financial Accounting Standards Board) proposal changes retiree healthcare benefit accounting Healthcare Financial Management: Journal of the Healthcare Financial Management Association 43(7): 48-9 52-4 56-7
Artsberg, K. 1993: Policy making and accounting change:influence on the choice of measurement principles in Swedish accounting European Accounting Review 2(1): 141-144
Marafioti, T.; Mancini, C.; Ascani, S.; Sabattini, E.; Zinzani, P.Luigi.; Pozzobon, M.; Pulford, K.; Falini, B.; Jaffe, E.S.; Müller-Hermelink, H-Konrad.; Mason, D.Y.; Pileri, S.A. 2004: Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease Haematologica 89(8): 957-964